Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

274.99
Delayed Data
As of Apr 29
 -6.09 / -2.17%
Today’s Change
242.07
Today|||52-Week Range
420.99
-10.24%
Year-to-Date

Today’s Trading

Previous close281.08
Today’s open278.24
Day’s range271.40 - 280.53
Volume1,941,004
Average volume (3 months)1,854,305
Market cap$61.6B
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+9.25%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)-3.87%
P/E ratio16.9
Price/Sales7.60
Price/Book6.56

Competitors

 Today’s
change
Today’s
% change
BXLTBaxalta Inc+1.06+2.59%
BAXBaxter International...-0.04-0.09%
JUNOJuno Therapeutics In...+0.05+0.12%
CTLTCatalent Inc-0.21-0.71%
Data as of 4:01pm ET, 04/29/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$4.58
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs